A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
Conditions
Advanced or Metastatic Colorectal Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
O Neal Comprehensive Cancer Center at UAB, Birmingham, Alabama, United States
University of Southern California, Los Angeles, California, United States
University of California, Los Angeles UCLA, Los Angeles, California, United States
Georgetown University Hospital, Washington D.C., District of Columbia, United States
H Lee Moffitt Cancer Center, Tampa, Florida, United States
University of Maryland School of Medicine, Baltimore, Maryland, United States
University of Michigan Health System, Ann Arbor, Michigan, United States
Start Midwest, Grand Rapids, Michigan, United States
Hattiesburg Clinic, Hattiesburg, Mississippi, United States
NYU Langone Long Island Clinical Research Associates, New York, New York, United States
Herbert Irving Comprehensive Cancer Center Columbia University Medical Center, New York, New York, United States
Stephenson Cancer Center, Oklahoma City, Oklahoma, United States
Vanderbilt Ingram Cancer Center, Nashville, Tennessee, United States
MD Anderson Cancer Center, Houston, Texas, United States
Institut Jules Bordet, Anderlecht, Belgium
Cliniques Universitaires Saint Luc, Brussels, Belgium
UZ Antwerpen, Edegem, Belgium
Universitair Ziekenhuis Gasthuisberg, Leuven, Belgium
BC Cancer Agency - Vancouver BC, Vancouver, British Columbia, Canada
The Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada
Princess Margaret Cancer Centre University Health Network, Toronto, Ontario, Canada
The Second Hospital To Dalian Medical University, Dalian, China
Sun Yat-sen University - The Sixth Affiliated Hospital Guangdong Gastrointestinal Hospital, Guangzhou, China
The Second Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, China
Hubei province tumor hospital, Wuhan, China
Asklepios Klinik Altona, Hamburg, Germany
Ludwig-Maximilians-Universitaet Muenchen, Munich, Germany
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
A O Ospedale Niguarda Ca Granda, Milan, Italy
Azienda Ospedaliero Universitaria Pisana, Pisa, Italy
University Malaya Medical Centre, Kuala Lumpur, Malaysia
Hospital Umum Sarawak, Kuching, Malaysia
Beacon Hospital Sdn Bhd, Petaling Jaya, Malaysia
Ad Vance Medical Research, Ponce, Puerto Rico
Pan American Center for Oncology Trials LLC, Rio Piedras, Puerto Rico
Seoul National University Hospital, Seoul, South Korea
Severance Hospital Yonsei University Health System, Seoul, South Korea
Asan Medical Center, Seoul, South Korea
Samsung Medical Center, Seoul, South Korea
The Catholic University of Korea Seoul St Mary s Hospital, Seoul, South Korea
Hosp Univ Vall D Hebron, Barcelona, Spain
Hosp. Gral. Univ. Gregorio Maranon, Madrid, Spain
Hosp. Univ. Ramon Y Cajal, Madrid, Spain
Hosp Univ Fund Jimenez Diaz, Madrid, Spain
Hosp Univ Hm Sanchinarro, Madrid, Spain
Hosp. Univ. Marques de Valdecilla, Santander, Spain
Hosp. Clinico Univ. de Valencia, Valencia, Spain
Changhua Christian Hospital, Changhua, Taiwan
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan
Chi Mei Medical Center Liu Ying, Liou Ying Township, Taiwan
National Cheng Kung University Hospital, Tainan, Taiwan
National Taiwan University Hospital, Taipei, Taiwan
Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan
Study leads
Janssen Research & Development, LLC Clinical Trial
Study Director
Janssen Research & Development, LLC